Communicating risk

Affiliations

Comment

Louisa Polak. Br J Gen Pract. 2014 Jun.

. 2014 Jun;64(623):277.

doi: 10.3399/bjgp14X680017.

¹ North Hill Medical Group, Colchester, and London School of Hygiene and Tropical Medicine. E-mail: louisa.polak@lshtm.ac.uk.

No abstract available

Comment on

Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice.
Harmsen CG, Kristiansen IS, Larsen PV, Nexøe J, Støvring H, Gyrd-Hansen D, Nielsen JB, Edwards A, Jarbøl DE. Harmsen CG, et al. Br J Gen Pract. 2014 Apr;64(621):e199-207. doi: 10.3399/bjgp14X677824. Br J Gen Pract. 2014. PMID: 24686884 Free PMC article. Clinical Trial.

1. Harmsen CG, Kristiansen IS, Larsen PV, et al. Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. Br J Gen Pract. 2014 doi: 10.3399/bjgp14X677824. - DOI - PMC - PubMed
1. Misselbrook D, Armstrong D. Patients’ responses to risk information about the benefits of treating hypertension. Br J Gen Pract. 2001;51:276–279. - PMC - PubMed
1. Summerskill WSM, Pope C. ‘I saw the panic rise in her eyes, and evidence-based medicine went out of the door.’ An exploratory qualitative study of the barriers to secondary prevention in the management of coronary heart disease. Fam Pract. 2002;19(6):605–610. - PubMed
1. Gupta M. Improved health or improved decision making? The ethical goals of EBM. J Eval Clin Pract. 2011;17(5):957–963. - PubMed